Huwiler Andrea, Döll Frauke, Ren Shuyu, Klawitter Sabine, Greening Anna, Römer Isolde, Bubnova Svetlana, Reinsberg Luise, Pfeilschifter Josef
pharmazentrum frankfurt/ZAFES, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
Biochim Biophys Acta. 2006 Mar;1761(3):367-76. doi: 10.1016/j.bbalip.2006.02.007. Epub 2006 Mar 10.
Sphingosine 1-phosphate (S1P) is a potent mitogenic signal generated from sphingosine by the action of sphingosine kinases (SKs). In this study, we show that in the human arterial endothelial cell line EA.hy 926 histamine induces a time-dependent upregulation of the SK-1 mRNA and protein expression which is followed by increased SK-1 activity. A similar upregulation of SK-1 is also observed with the direct protein kinase C activator 12-O-tetradecanoylphorbol-13-acetate (TPA). In contrast, SK-2 activity is not affected by neither histamine nor TPA. The increased SK-1 protein expression is due to stimulated de novo synthesis since cycloheximide inhibited the delayed SK-1 protein upregulation. Moreover, the increased SK-1 mRNA expression results from an increased promoter activation by histamine and TPA. In mechanistic terms, the transcriptional upregulation of SK-1 is dependent on PKC and the extracellular signal-regulated protein kinase (ERK) cascade since staurosporine and the MEK inhibitor U0126 abolish the TPA-induced SK-1 induction. Furthermore, the histamine effect is abolished by the H1-receptor antagonist diphenhydramine, but not by the H2-receptor antagonist cimetidine. Parallel to the induction of SK-1, histamine and TPA stimulate an increased migration of endothelial cells, which is prevented by depletion of the SK-1 by small interfering RNA (siRNA). To appoint this specific cell response to a specific PKC isoenzyme, siRNA of PKC-alpha, -delta, and -epsilon were used to selectively downregulate the respective isoforms. Interestingly, only depletion of PKC-alpha leads to a complete loss of TPA- and histamine-triggered SK-1 induction and cell migration. In summary, these data show that PKC-alpha activation in endothelial cells by histamine-activated H1-receptors, or by direct PKC activators leads to a sustained upregulation of the SK-1 protein expression and activity which, in turn, is critically involved in the mechanism of endothelial cell migration.
1-磷酸鞘氨醇(S1P)是鞘氨醇激酶(SKs)作用于鞘氨醇产生的一种强效促有丝分裂信号。在本研究中,我们发现,在人动脉内皮细胞系EA.hy 926中,组胺可诱导SK-1 mRNA和蛋白表达呈时间依赖性上调,随后SK-1活性增加。用直接蛋白激酶C激活剂12-O-十四酰佛波醇-13-乙酸酯(TPA)也观察到类似的SK-1上调。相反,SK-2活性不受组胺和TPA的影响。SK-1蛋白表达增加是由于从头合成受刺激,因为放线菌酮抑制了延迟的SK-1蛋白上调。此外,SK-1 mRNA表达增加是由于组胺和TPA增强了启动子激活。从机制上讲,SK-1的转录上调依赖于蛋白激酶C(PKC)和细胞外信号调节蛋白激酶(ERK)级联反应,因为星形孢菌素和MEK抑制剂U0126可消除TPA诱导的SK-1诱导。此外,组胺的作用可被H1受体拮抗剂苯海拉明消除,但不能被H2受体拮抗剂西咪替丁消除。与SK-1的诱导平行,组胺和TPA刺激内皮细胞迁移增加,而小干扰RNA(siRNA)耗尽SK-1可阻止这种迁移。为了确定这种特定的细胞反应是由特定的PKC同工酶引起的,使用PKC-α、-δ和-ε的siRNA选择性下调各自的同工型。有趣的是,只有PKC-α的耗尽会导致TPA和组胺触发的SK-1诱导和细胞迁移完全丧失。总之,这些数据表明,组胺激活的H1受体或直接PKC激活剂在内皮细胞中激活PKC-α会导致SK-1蛋白表达和活性的持续上调,这反过来又在内皮细胞迁移机制中起关键作用。